查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575300

雙丙戊酸鈉市場：按產品類型、應用、最終用戶、分銷管道 - 2025-2030 年全球預測

Divalproex Sodium Market by Product Type (Delayed-Release Tablets, Extended-Release Tablets, Immediate-Release Tablets), Application (Bipolar Disorder, Epilepsy, Migraine), End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年雙丙戊酸鈉市值為23.4億美元，預計2024年將達24.7億美元，複合年成長率為6.19%，預計到2030年將達到35.7億美元。

雙丙戊酸鈉是一種抗驚厥藥，主要用於治療驚厥性疾病、躁鬱症和預防偏頭痛，其市場範圍充滿活力，遍及整個製藥行業。對雙丙戊酸鈉的需求在於其作為神經和精神疾病的重要治療選擇的既定作用，透過穩定情緒和預防偏頭痛來改善患者的生活品質，並提供了重要的應用優勢。最終用途多種多樣，包括醫院、診所和療養院，事實證明在各種醫療保健環境中已被廣泛接受了。主要成長動力包括神經系統疾病盛行率上升、精神疾病意識和診斷的提高以及擴大治療應用的研究進展。個人化醫療的日益成長以及人工智慧在藥物開發中的整合帶來了最新的潛在機會，這可以增強患者的針對性並支持雙丙戊酸鈉的新配方。抓住這些機會的治療方法包括投資個人化治療解決方案以及與科技公司建立策略聯盟以利用人工智慧功能。儘管潛力巨大，但該市場仍面臨副作用、嚴格的監管要求以及學名藥競爭等限制和挑戰，這可能會阻礙成長前景。此外，主要市場的醫療保健政策不確定性可能會影響市場穩定性。創新和研究可能集中在開發提高患者依從性的劑型，例如緩釋性製劑，並探索提高療效同時減少副作用的組合療法。此外，透過研究其機制，可能會發現其在其他精神和神經疾病中的應用。隨著市場競爭激烈，幾家主要企業投資研發以實現產品差異化，創新和成本效率措施對於持續的業務成長和競爭力變得尤為重要。

主要市場統計
基準年[2023] 23.4億美元
預測年份 [2024] 24.7億美元
預測年份 [2030] 35.7億美元
複合年成長率（%） 6.19%

市場動態：揭示快速發展的雙丙戊酸鈉市場的關鍵市場洞察

雙丙戊酸鈉市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 醫學研究進展提高了對雙極性情感障礙的了解和雙丙戊酸鈉的治療效果
    • 政府支持心理健康治療的措施促進了雙丙戊酸鈉市場的成長
    • 由於已開發國家和開發中國家醫療費用的上漲，改善雙丙戊酸鈉的獲取
    • 透過開發雙丙戊酸鈉新配方來提高患者依從性並減少副作用
  • 市場限制因素
    • 供應鏈中斷和原料短缺影響生產計劃和市場供應
    • 廣泛的臨床測試要求延長了新配方和創新產品的上市時間
  • 市場機會
    • 雙丙戊酸鈉緩釋緩釋性的創新可提高患者依從性和治療結果
    • 開發雙丙戊酸鈉組合藥物增強多症狀神經系統疾病的治療效果
    • 透過個人化雙丙戊酸鈉劑量和給藥方案解決服務不足的患者群體問題
  • 市場挑戰
    • 由於人們越來越擔心雙丙戊酸鈉的潛在副作用和安全性，採用有限
    • 雙丙戊酸鈉市場維持供應鏈效率和管理原料短缺的挑戰

波特的五力：駕馭雙丙戊酸鈉市場的策略工具

波特的五力架構是了解雙丙戊酸鈉市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解雙丙戊酸鈉市場的外部影響

外部宏觀環境因素在塑造雙丙戊酸鈉市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解雙丙戊酸鈉市場的競爭狀況

對雙丙戊酸鈉市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣雙丙戊酸鈉市場供應商的績效評估

FPNV定位矩陣是評估雙丙戊酸鈉市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了雙丙戊酸鈉市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對雙丙戊酸鈉市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫學研究的進步提高了對雙極性情感障礙的認知和治療效果。雙丙戊酸鈉
      • 政府支持心理健康治療的舉措推動了 Gival Pro Extra 市場的成長
      • 已開發國家和新興國家不斷上漲的醫療費用改善了獲得醫療服務的機會
      • 開發雙丙戊酸鈉新配方以提高患者依從性並減少副作用
    • 抑制因素
      • 供應鏈中斷和原料短缺影響生產計劃和市場供應
      • 廣泛的臨床試驗要求延長了新配方和創新的上市時間
    • 機會
      • 雙丙戊酸鈉緩釋性的創新可提高患者依從性和治療結果
      • 開發雙丙戊酸鈉藥物組合以提高治療多症狀神經系統疾病的功效
      • 透過個人化雙丙戊酸鈉劑量和給藥方案瞄準服務不足的患者群體
    • 任務
      • 人們越來越擔心雙丙戊酸鈉的潛在副作用和安全性，限制了其採用
      • 雙丙戊酸鈉市場維持供應鏈效率和管理原料短缺的挑戰
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章雙丙戊酸鈉市場：依產品類型

  • 緩釋片劑
    • 品牌名稱
    • 非專利的
  • 緩釋片
    • 品牌名稱
    • 非專利的
  • 速效錠劑
    • 品牌名稱
    • 非專利的
  • 將膠囊撒開
    • 品牌名稱
    • 非專利的

第7章雙丙戊酸鈉市場：依應用分類

  • 躁鬱症
    • 急性躁鬱症
    • 輔助性治療
    • 維持治療
  • 癲癇
    • 輔助性治療
    • 單一療法
  • 偏頭痛
    • 預防

第 8 章 雙丙戊酸鈉市場：依最終用戶分類

  • 診所
    • 普通科診所
    • 專科診所
  • 居家護理
    • 看護者管理
    • 病患管理
  • 醫院
    • 住院病人
    • 門診

第 9 章 雙丙戊酸鈉市場：按分銷管道

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章美洲雙丙戊酸鈉市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區雙丙戊酸鈉市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲雙丙戊酸鈉市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0549

The Divalproex Sodium Market was valued at USD 2.34 billion in 2023, expected to reach USD 2.47 billion in 2024, and is projected to grow at a CAGR of 6.19%, to USD 3.57 billion by 2030.

Divalproex Sodium, an anticonvulsant medication primarily used for treating seizure disorders, bipolar disorder, and to prevent migraines, has a dynamic market scope extending across the pharmaceutical industry. The necessity of Divalproex Sodium lies in its established role as an essential treatment option for neurological and psychiatric conditions, offering significant application benefits by stabilizing mood and preventing migraines, thus improving patient quality of life. The end-use scope encompasses hospitals, clinics, and nursing homes, attesting to its broad acceptance in various healthcare settings. Key growth drivers include rising prevalence of neurological disorders, increased awareness and diagnosis of psychiatric conditions, and ongoing research into its expanded therapeutic applications. Latest potential opportunities arise from the growing trend of personalized medicine and the integration of AI in drug development, which could enhance patient targeting and support novel formulations of Divalproex Sodium. Recommendations to seize these opportunities include investing in personalized treatment solutions and strategic partnerships with technology firms to leverage AI capabilities. Despite its potential, the market faces limitations and challenges such as side-effect profiles, stringent regulatory requirements, and the competition from generic drugs, which could hinder growth prospects. Further, uncertainty in healthcare policies across major markets may affect market stability. Innovation and research could pivot towards the development of dosage forms that enhance patient adherence, such as extended-release formulations, and exploring combinatorial therapies that increase efficacy while reducing adverse effects. Additionally, research into its mechanisms could uncover applications in other psychiatric or neurological disorders. The nature of the market is highly competitive with several key players investing in R&D to ensure product differentiation, presenting an environment where innovation and cost-efficiency measures are particularly critical for sustained business growth and gaining a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 2.34 billion
Estimated Year [2024] USD 2.47 billion
Forecast Year [2030] USD 3.57 billion
CAGR (%) 6.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Divalproex Sodium Market

The Divalproex Sodium Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Advancements in medical research improving understanding of bipolar disorder and treatment effectiveness with divalproex sodium
    • Government initiatives supporting mental health treatment boosting divalproex sodium market growth
    • Increasing healthcare expenditure in developed and developing countries enhancing access to divalproex sodium
    • Developing novel formulations of divalproex sodium providing better patient compliance and reduced side effects
  • Market Restraints
    • Supply chain disruptions and raw material shortages impacting production timelines and market supply
    • Extensive clinical trial requirements elongating time to market for new formulations and innovations
  • Market Opportunities
    • Innovation in extended-release formulations of divalproex sodium to improve patient compliance and therapeutic outcomes
    • Developing divalproex sodium drug combinations for enhanced efficacy in treating multi-symptomatic neurological conditions
    • Targeting underserved patient demographics through personalized divalproex sodium dosing and administration schedules
  • Market Challenges
    • Increasing concern over potential side effects and safety profile of divalproex sodium limiting its adoption
    • Challenges in maintaining supply chain efficiency and managing raw material shortages in the divalproex sodium market

Porter's Five Forces: A Strategic Tool for Navigating the Divalproex Sodium Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Divalproex Sodium Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Divalproex Sodium Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Divalproex Sodium Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Divalproex Sodium Market

A detailed market share analysis in the Divalproex Sodium Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Divalproex Sodium Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Divalproex Sodium Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Divalproex Sodium Market

A strategic analysis of the Divalproex Sodium Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Divalproex Sodium Market, highlighting leading vendors and their innovative profiles. These include Allergan plc, Amgen Inc., AstraZeneca, Avkare Inc., Boehringer Ingelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Hikma Pharmaceuticals, Intas Pharmaceuticals, Janssen Pharmaceuticals, Jubilant Life Sciences, Merck & Co., Inc., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi S.A., Sigmapharm Laboratories, Takeda Pharmaceutical Company Limited, and UCB S.A..

Market Segmentation & Coverage

This research report categorizes the Divalproex Sodium Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Delayed-Release Tablets, Extended-Release Tablets, Immediate-Release Tablets, and Sprinkle Capsules. The Delayed-Release Tablets is further studied across Brand Name and Generic. The Extended-Release Tablets is further studied across Brand Name and Generic. The Immediate-Release Tablets is further studied across Brand Name and Generic. The Sprinkle Capsules is further studied across Brand Name and Generic.
  • Based on Application, market is studied across Bipolar Disorder, Epilepsy, and Migraine. The Bipolar Disorder is further studied across Acute Mania, Adjunctive Therapy, and Maintenance Treatment. The Epilepsy is further studied across Adjunctive Therapy and Monotherapy. The Migraine is further studied across Prophylaxis.
  • Based on End User, market is studied across Clinics, Homecare, and Hospitals. The Clinics is further studied across General Clinics and Specialty Clinics. The Homecare is further studied across Caregiver Administered and Patient Administered. The Hospitals is further studied across Inpatient and Outpatient.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Advancements in medical research improving understanding of bipolar disorder and treatment effectiveness with divalproex sodium
      • 5.1.1.2. Government initiatives supporting mental health treatment boosting divalproex sodium market growth
      • 5.1.1.3. Increasing healthcare expenditure in developed and developing countries enhancing access to divalproex sodium
      • 5.1.1.4. Developing novel formulations of divalproex sodium providing better patient compliance and reduced side effects
    • 5.1.2. Restraints
      • 5.1.2.1. Supply chain disruptions and raw material shortages impacting production timelines and market supply
      • 5.1.2.2. Extensive clinical trial requirements elongating time to market for new formulations and innovations
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation in extended-release formulations of divalproex sodium to improve patient compliance and therapeutic outcomes
      • 5.1.3.2. Developing divalproex sodium drug combinations for enhanced efficacy in treating multi-symptomatic neurological conditions
      • 5.1.3.3. Targeting underserved patient demographics through personalized divalproex sodium dosing and administration schedules
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing concern over potential side effects and safety profile of divalproex sodium limiting its adoption
      • 5.1.4.2. Challenges in maintaining supply chain efficiency and managing raw material shortages in the divalproex sodium market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Divalproex Sodium Market, by Product Type

  • 6.1. Introduction
  • 6.2. Delayed-Release Tablets
    • 6.2.1. Brand Name
    • 6.2.2. Generic
  • 6.3. Extended-Release Tablets
    • 6.3.1. Brand Name
    • 6.3.2. Generic
  • 6.4. Immediate-Release Tablets
    • 6.4.1. Brand Name
    • 6.4.2. Generic
  • 6.5. Sprinkle Capsules
    • 6.5.1. Brand Name
    • 6.5.2. Generic

7. Divalproex Sodium Market, by Application

  • 7.1. Introduction
  • 7.2. Bipolar Disorder
    • 7.2.1. Acute Mania
    • 7.2.2. Adjunctive Therapy
    • 7.2.3. Maintenance Treatment
  • 7.3. Epilepsy
    • 7.3.1. Adjunctive Therapy
    • 7.3.2. Monotherapy
  • 7.4. Migraine
    • 7.4.1. Prophylaxis

8. Divalproex Sodium Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
    • 8.2.1. General Clinics
    • 8.2.2. Specialty Clinics
  • 8.3. Homecare
    • 8.3.1. Caregiver Administered
    • 8.3.2. Patient Administered
  • 8.4. Hospitals
    • 8.4.1. Inpatient
    • 8.4.2. Outpatient

9. Divalproex Sodium Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Divalproex Sodium Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Divalproex Sodium Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Divalproex Sodium Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allergan plc
  • 2. Amgen Inc.
  • 3. AstraZeneca
  • 4. Avkare Inc.
  • 5. Boehringer Ingelheim
  • 6. Bristol-Myers Squibb Company
  • 7. Eli Lilly and Company
  • 8. GlaxoSmithKline plc
  • 9. Hikma Pharmaceuticals
  • 10. Intas Pharmaceuticals
  • 11. Janssen Pharmaceuticals
  • 12. Jubilant Life Sciences
  • 13. Merck & Co., Inc.
  • 14. Novartis AG
  • 15. Pfizer Inc.
  • 16. Roche Holding AG
  • 17. Sanofi S.A.
  • 18. Sigmapharm Laboratories
  • 19. Takeda Pharmaceutical Company Limited
  • 20. UCB S.A.

LIST OF FIGURES

  • FIGURE 1. DIVALPROEX SODIUM MARKET RESEARCH PROCESS
  • FIGURE 2. DIVALPROEX SODIUM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIVALPROEX SODIUM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIVALPROEX SODIUM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIVALPROEX SODIUM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIVALPROEX SODIUM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIVALPROEX SODIUM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIVALPROEX SODIUM MARKET DYNAMICS
  • TABLE 7. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BRAND NAME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BRAND NAME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BRAND NAME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BRAND NAME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY ACUTE MANIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY ADJUNCTIVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY MAINTENANCE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY ADJUNCTIVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY CAREGIVER ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY PATIENT ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL DIVALPROEX SODIUM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES DIVALPROEX SODIUM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 168. AUSTRALIA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 180. CHINA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 181. CHINA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 182. CHINA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. INDIA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 194. INDIA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 195. INDIA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 196. INDIA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 206. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 208. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 209. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 210. INDONESIA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 219. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 220. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 222. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 223. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 224. JAPAN DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 232. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 233. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 234. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 236. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 237. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 238. MALAYSIA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 246. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 248. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 250. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 252. PHILIPPINES DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 256. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 258. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 260. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 261. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 262. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 264. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 265. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 266. SINGAPORE DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH KOREA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 283. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 284. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 285. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 286. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 288. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 289. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 290. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 292. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 293. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 294. TAIWAN DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 295. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 297. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 298. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 299. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 300. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 302. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 303. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 304. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 305. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 306. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 307. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 308. THAILAND DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 309. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 311. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 312. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 313. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 314. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 316. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 317. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 318. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 320. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 321. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 322. VIETNAM DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 336. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA DIVALPROEX SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 338. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 339. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY DELAYED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 340. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY EXTENDED-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 341. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY IMMEDIATE-RELEASE TABLETS, 2018-2030 (USD MILLION)
  • TABLE 342. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY SPRINKLE CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 343. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 344. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY BIPOLAR DISORDER, 2018-2030 (USD MILLION)
  • TABLE 345. DENMARK DIVALPROEX SODIUM MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
  • TABLE 346. DENMARK DIVALPROEX SODIUM M